These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2134216)

  • 1. Discrepancies in assessment of metabolic regulation in insulin-dependent diabetes mellitus--can we do without measurements of glycated haemoglobin?
    Larsen ML; Petersen PH; Hørder M; Mogensen EF
    Diabetes Res; 1990 Jun; 14(2):75-8. PubMed ID: 2134216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical usefulness of glucated haemoglobin in diabetes care evaluated by use of a medical technology assessment strategy.
    Larsen ML
    Dan Med Bull; 1997 Jun; 44(3):303-15. PubMed ID: 9233549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic evaluation of non-insulin-dependent diabetes in primary health care--the clinical usefulness of glycated haemoglobin measurements.
    Larsen ML; Hørder M
    Scand J Prim Health Care; 1989 Oct; 7(3):167-71. PubMed ID: 2587872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycated haemoglobin and other biochemical parameters in Sudanese diabetics.
    Atabani GS; Saeed BO; el Mahdi EM; Adam ME; Hassan DA
    Ann Clin Biochem; 1989 Jul; 26 ( Pt 4)():332-4. PubMed ID: 2764486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of the compliance with blood glucose monitoring in young insulin-dependent diabetes mellitus patients by the Sensorlink system.
    Dorchy H; Roggemans MP
    Diabetes Res Clin Pract; 1997 May; 36(2):77-82. PubMed ID: 9229191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated serum proteins and glycosylated hemoglobin in the assessment of glycemic control in insulin-dependent and non-insulin-dependent diabetes mellitus.
    Beisswenger PJ; Healy JC; Shultz EK
    Metabolism; 1993 Aug; 42(8):989-92. PubMed ID: 8345823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both the frequency of HbA
    Schwandt A; Best F; Biester T; Grünerbel A; Kopp F; Krakow D; Laimer M; Wagner C; Holl RW;
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28544457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of glycaemic control limits using the Ames DCA 2000 HbA1c analyser.
    Rumley AG; Kilpatrick ES; Dominiczak MH; Small M
    Diabet Med; 1993 Dec; 10(10):976-9. PubMed ID: 8306596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of HbA1c in multicentre diabetes trials - should blood samples be tested locally or sent to a central laboratory: an agreement analysis.
    Arch BN; Blair J; McKay A; Gregory JW; Newland P; Gamble C
    Trials; 2016 Oct; 17(1):517. PubMed ID: 27776543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
    Vinagre I; Álvarez P; García N; Roura G; Conget I;
    Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between a rapid glycohaemoglobin (HbA1c) immunoassay and other indices of glycaemic control.
    Le Marois E; Bruzzo F; Reach G; Guyon F; Luo J; Boillot J; Slama G; Selam JL
    Acta Diabetol; 1996 Sep; 33(3):232-5. PubMed ID: 8904931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
    Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M
    Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients.
    Tarnow L; Kjeld T; Knudsen E; Major-Pedersen A; Parving HH
    Diabetologia; 2000 Jun; 43(6):794-9. PubMed ID: 10907125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated hemoglobin. Reaction and biokinetic studies. Clinical application of hemoglobin A1c in the assessment of metabolic control in children with diabetes mellitus.
    Mortensen HB
    Dan Med Bull; 1985 Dec; 32(6):309-28. PubMed ID: 3908003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HbA1c can be a useful glycemic control marker for patients with neonatal diabetes mellitus older than 20 weeks of age.
    Furuya A; Suzuki S; Koga M; Oshima M; Amamiya S; Nakao A; Wada K; Okuhara K; Hayano S; Matsuo K; Tanahashi Y; Azuma H
    Clin Chim Acta; 2014 Sep; 436():93-6. PubMed ID: 24854496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylated hemoglobin in insulin-dependent diabetes mellitus related to preeclampsia.
    Hsu CD; Hong SF; Nickless NA; Copel JA
    Am J Perinatol; 1998 Mar; 15(3):199-202. PubMed ID: 9572378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of automated fructosamine and HbA1c methods for monitoring diabetes in pregnancy.
    Kennedy DM; Johnson AB; Hill PG
    Ann Clin Biochem; 1998 Mar; 35 ( Pt 2)():283-9. PubMed ID: 9547902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter cross-sectional analysis of values of glycated haemoglobin (HbA1c) in Polish children and adolescents with long-term type 1 diabetes in Poland: PolPeDiab study group.
    Jarosz-Chobot P; Polańska J; Myśliwiec M; Szadkowska A; Fendler W; Kamińska H; Chumiecki M; Mianowska B; Techmańska I; Sztangierska B; Młynarski W;
    Pediatr Endocrinol Diabetes Metab; 2012; 18(4):125-9. PubMed ID: 23739615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate sources and glycaemic control in Type 1 diabetes mellitus. EURODIAB IDDM Complications Study Group.
    Buyken AE; Toeller M; Heitkamp G; Irsigler K; Holler C; Santeusanio F; Stehle P; Fuller JH
    Diabet Med; 2000 May; 17(5):351-9. PubMed ID: 10872533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.